It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks…

from Yahoo Finance https://ift.tt/3025hxf

The company, whose Chief Executive Officer Elon Musk has spoken against further government aid as Congress debates another round of stimulus, said that along with cost cuts, the benefits had offset almost all of its costs due to the idling of factories in this year’s lockdowns. Tesla’s only U.S. vehicle factory — in California, where most of its cars are produced — was shut down for some six weeks in the second quarter ended June after an initial standoff with local authorities. Reuters could not immediately verify which government assistance the company received and in what country.

from Yahoo Finance https://ift.tt/3g2VeO2

(Bloomberg) — Remington Outdoor Co. filed for bankruptcy for the second time in two years with plans to sell the 200-year-old maker of firearms.The company said reduced gun sales prevented it from making money even after restructuring its finances in its first bankruptcy. Remington had $437.5 million in sales last year, about half the business it did in 2016, according to court papers filed in Decatur, Alabama.The company owes various lenders more than $250 million, including a $12.5 million debt to Remington’s home town of Huntsville, Alabama, which put up a loan to help upgrade a manufacturing plant there.The Chapter 11 filing allows the company to keep operating while it devises plans to turn around the business and pay its creditors.Remington will continue its hunt for a buyer, which began months before seeking court protection from creditors. The company landed one potential offer for all of its assets, but the unnamed suitor delayed making a final decision after the deal became public, company chief executive Ken D’Arcy said in court papers. The Wall Street Journal reported that the company held talks with the Navajo Nation about a sale, but those discussions fell apart.D’Arcy said the company is continuing to talk to its unnamed potential buyer as well as others.Earlier FilingRemington went bankrupt before in February 2018. It was felled by too much debt and overstocked gun dealers, who were left with unsold weapons after the surprise loss of Hillary Clinton — an advocate of gun control — to Donald Trump in the 2016 election. Cerberus Capital Management had acquired Remington in 2007, and the firearms and ammunition giant accumulated nearly $1 billion in debt.It emerged from bankruptcy in May 2018, minus more than $775 million of debt, with ownership transferred to senior lenders. This time, Remington is heading back to court even as gun sales revive amid civil unrest in the U.S. The company said it couldn’t take advantage of increased demand because the pandemic disrupted its manufacturing.In the months leading up to its prior bankruptcy, the company had trouble attracting capital and potential buyers because of the controversy over arms sales. Family members of nine children and educators killed in the 2012 Sandy Hook Elementary School massacre sued Remington over its marketing of the semiautomatic military-style rifle the shooter used. A trial date was set for 2021.Remington said it continues to fight all the product liability lawsuits its faces.Advisers to Remington include lawyers at O’Melveny & Myers and Akin Gump Strauss Hauer & Feld, restructuring consultants at M-III Partners, and bankers at Ducera Partners, according to the petition.The case is Remington Outdoor Company Inc., 20-81688-11, U.S. Bankruptcy Court for the Northern District of Alabama.To view the docket in Bloomberg Law, click here.(Updates with details of sale efforts in the fifth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/39Dr8hU

United Airlines Holdings Inc. (UAL) has communicated to two regional airlines, ExpressJet (XJT) and CommutAir, that it will continue to work with only one of them.In a report from Reuters on July 28, a pilot union letter revealed United's intentions, which would potentially result in a significant revenue loss for the unchosen carrier. ExpressJet and CommutAir work exclusively for United Airlines.Before the pandemic, United Airlines expanded its domestic network by making agreements with regional airlines, which offered cheaper terms. However, with reduced travel due to COVID-19, United has been forced to scale its plans and reduce its workforce. This follows a trend of most airlines also decreasing scheduled flights for the rest of summer and fall in an attempt to retain cash.In an email to Reuters, United said, "We've been clear for months now that we expect to be a smaller airline in response to the historic impact that the COVID-19 pandemic has had on our business. That means we've cut our schedules and our costs across the operation – and we do anticipate it will continue to impact the relationships we have with our regional partners."After United communicated that it would only require one E145 carrier in the future, ExpressJet Union chairman wrote a letter to its pilots, saying that there would be a "dramatic impact" on the airline's future.The letter stated, "While ExpressJet offers many attributes that make us an attractive long-term partner, cost has reared its ugly head once again, and we have been asked by our management team to close the gap between our costs and those at CommutAir."ExpressJet is considered bigger than CommutAir, with a more tenured staff and a larger fleet of about 95 compared to 37 at CommutAir.On a July 22 Q2 earnings call, United Airlines CCO Andrew Nocella commented on the company's future saying, "Our best guess is demand, as measured by revenue, will recover over time to be down approximately 50% and then plateau at that level until a vaccine is widely distributed."UBS analyst Myles Walton reduced his 2020 earnings estimate by 20% and raised his loss estimates for 2021 and 2022, saying that he believes the stock is relatively weak. He maintained a Hold rating on the shares and a price target of $25 which implies a downside potential of 23%UAL stock is down 63% year-to-date with a Moderate Buy analyst consensus that breaks down into 5 Buy ratings versus 7 Hold ratings and no Sell ratings. The $42.70 average price target suggests 32% upside potential for the shares in the coming 12 months. (See UAL’s stock analysis on TipRanks).Related News: Boeing Is Said To Delay New 777X As Demand For Large Jets Throttles Avolon Cancels 27 Of Boeing 737 Max Aircraft Order American Airlines, JetBlue Partner To Boost Flight Options In Bid For Covid-19 Recovery More recent articles from Smarter Analyst: * SAP, E.ON Partner To Develop Cost-Cutting Cloud Energy Data Platform * Amazon Shares Rise As Analysts See More Upside * Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate * Walgreens Drops After CEO Steps Down

from Yahoo Finance https://ift.tt/331FOWx

Emergent BioSolutions Inc. (EBS) has signed a $174 million deal to provide contract development and manufacturing for AstraZeneca’s (AZN) COVID-19 vaccine candidate, AZD1222.As part of the agreement, Emergent will start this year to produce drug substance at large scale for commercial supply. The contract valid until 2021, follows a $87 million contract in June, which Emergent signed for the development of AstraZeneca’s vaccine candidate. Together the agreements bring AstraZeneca’s commitment to a total of $261 million.AstraZeneca, which is developing AZD1222 together with Oxford University, has in recent weeks signed supply chain agreements for the capacity to produce 2 billion doses of its vaccine candidate. The British drugmaker has inked supply deals with the U.S. and European Union countries.“Emergent is driven by our desire to advance solutions that will make an impact on this pandemic,” said Emergent CEO Robert G. Kramer. “Sharing a passion for science, we are encouraged by AstraZeneca’s investigational COVID-19 vaccine and look forward to supporting its continued progress.”Manufacturing activities under the latest agreement will be performed at Emergent’s Baltimore Bayview facility. The facility is designed for rapid manufacturing of large quantities of vaccines and treatments during public health emergencies. It has the capacity to produce tens to hundreds of millions of doses of vaccine on an annual basis, based upon the platform technology being used.AstraZeneca’s AZD1222 is one of several vaccine candidates supported by Operation Warp Speed (OWS), the U.S. government program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines available for Americans by Jan. 2021.Emergent said that it will provide an update to its 2020 financial outlook incorporating expectations related to this agreement when it reports its second-quarter financial results on July 30.Shares in Emergent rose 5.5% to $94.78 at the close on Monday taking this year’s advance to an impressive 76%.Chardan Capital analyst Keay Nakae last month reiterated a Buy rating on the stock with a $86 price target.“We believe that the company has established itself as a preferred supplier of biodefense vaccines and other products to the U.S. government under multiyear sales contracts,” Nakae wrote in a note to investors. “The company’s ability to land several new manufacturing contracts since the beginning of this year is just another example of one of Emergent's key strengths, its longstanding relationships with the relevant government agencies.”The rest of the Street resonates with Nakae’s bullish outlook. The Strong Buy analyst consensus boasts 4 Buy ratings versus 1 Hold rating. Meanwhile, the $90.60 average analyst price target implies 4.4% downside potential for the shares in the next 12 months. (See EBS stock analysis on TipRanks).Related News: Pfizer, BioNTech Rise As Phase 2/3 Covid-19 Vaccine Trial Kicks Off AstraZeneca To Pay Up To $6B For Daiichi Cancer Drug Deal Novartis Unveils €150M Antibiotics Investment For Europe More recent articles from Smarter Analyst: * Walgreens Drops After CEO Steps Down * Kinder Morgan To Raise $1.25B From Bond Sale To Repay Debt Early * Kontoor Pops 11% As Goldman Flips From Bear To Bull * Chi-Med, Eli Lilly Link Up For Commercializing Elunate In China

from Yahoo Finance https://ift.tt/3074WcB

Amazon (AMZN) rose 1.5% on Monday after Merill Lynch and Wells Fargo, among others, lifted the price target on the stock. The analysts’ optimism comes ahead of the company’s 2Q earnings on July 30. Amazon has benefited from an online user boom helping its shares surge over 65% so far this year.Merrill Lynch analyst Justin Post raised the price target to $3,280 (7.4% upside potential) from $3,000. Meanwhile, Wells Fargo analyst Brian Fitzgerald hiked it to $3,600 from $3,000.Wedbush analyst Michael Pachter lifted the price target to $3,500 from $3,050. Pachter believes that “Covid-19 and the stay-at-home response for many consumers should result in substantial revenue upside in Q2, with the company’s burgeoning grocery business likely a key driver.” Further, Pachter added, “We expect many consumers to remain reticent to return to normal consumption patterns so long as the threat of infection is meaningful.”Credit Suisse analyst Stephen Ju increased the price target to $3,400 from $2,760, while Telsey Advisory analyst Joe Feldman raised it to $3,600 from $2,800.Currently, the Street has a bullish outlook on the stock. The Strong Buy analyst consensus is based on 37 Buys and 2 Holds. The average price target of $3,194.22 implies an upside potential of 4.6%. (See AMZN stock analysis on TipRanks).Related News: AMD Biggest Beneficiary of Intel’s 7nm Delay, Says 5-Star Analyst Intel Faces Analysts’ Wrath, Stock Slips Over 16% Verizon (VZ) Stock Looks Attractive After Earnings, Says 5-Star Analyst More recent articles from Smarter Analyst: * Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate * Walgreens Drops After CEO Steps Down * Kinder Morgan To Raise $1.25B From Bond Sale To Repay Debt Early * Kontoor Pops 11% As Goldman Flips From Bear To Bull

from Yahoo Finance https://ift.tt/2X3HsTW

Here is why gold prices are going through the roof.

from Yahoo Finance https://ift.tt/39BgIPS

Stock futures pointed to a lower open Tuesday morning, with updates on the Covid-19 vaccine front, stimulus talks in Washington and corporate earnings results front and center.

from Yahoo Finance https://ift.tt/30URWWK

Does the July share price for Sohu.com Limited (NASDAQ:SOHU) reflect what it's really worth? Today, we will estimate…

from Yahoo Finance https://ift.tt/307cWKK

In the hearts of New York and metro Los Angeles, Rite Aid deployed the technology in largely lower-income, non-white neighbourhoods, according to a Reuters analysis. In telephone and email exchanges with Reuters since February, Rite Aid confirmed the existence and breadth of its facial recognition programme.

from Yahoo Finance https://ift.tt/39xYcYk